3.0
5 May 2015
Former employee
Cambridge, MA
Recommend
CEO approval
Business outlook
Pros
Enough funding to attend scientific conferences, clear direction for objectives.
Cons
Objectives change every 6 months requiring projects to be abandoned - and leaving outside collaborators scratching their heads. People are put in charge of departments where they have no experience. Global staff specifically exclude US staff from making decisions - even those with FDA or other US entities.